ipidacrine ipidacrine ipidacrine (neiromidin) is a drug first synthesized by the national research center for biologically active compounds in the russian federation. this compound is a ring-constricted derivative of tacrine (cognex). ipidacrineclinical datatrade namesneiromidinother namesamiridine; nik-247atc coden06da05 (who) legal statuslegal status us: unscheduled not fda approved identifiers iupac name 2,3,5,6,7,8-hexahydro-1h-cyclopentaquinolin-9-amine cas number62732-44-9pubchem cid604519chemspider525510uniicv71vtp0vnchemblchembl130880comptox dashboard (epa)dtxsid7048299 echa infocard100.201.385 chemical and physical dataformulac12h16n2molar mass188.274 g·mol−13d model (jsmol)interactive image smiles c1ccc2c(c(c3c(n2)ccc3)n)c1 inchi inchi=1s/c12h16n2/c13-12-8-4-1-2-6-10(8)14-11-7-3-5-9(11)12/h1-7h2,(h2,13,14)key:ylusmkajiqoxpv-uhfffaoysa-n ipidacrine is a reversible acetylcholinesterase inhibitor used in memory disorders of different origins. ipidacrine directly stimulates impulse transmission in the central nervous system and neuromuscular synapses by blocking membrane potassium channels. ipidacrine enhances not only choline, but also adrenaline, serotonin, histamine, and oxytocin effects on smooth muscle.